Genmab A/S ( GMAB) - Key Metrics
GMAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $110.17 | $3.23 | $31.35 | $29.98 |
| 2025Q3 | $105.97 | $6.51 | $8.70 | $8.67 |
| 2025Q2 | $94.90 | $34.47 | $6.36 | $5.34 |
| 2025Q1 | $79.53 | $20.79 | $30.60 | $27.40 |
GMAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 156.98 |
| 2025Q3 | ? | 74.02 |
| 2025Q2 | ? | 9.54 |
| 2025Q1 | ? | 16.11 |
GMAB
Price: $24.73
52 week price:
Earnings Per Share: 1.31 USD
P/E Ratio: 20.27
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 221594
Market Capitalization: 16.3 billion